Episode 510: ADCs in Prostate Cancer

from The Uromigos · host The Uromigos

Tanya Dorff joins Tom and Brian to discuss her ASCO 2026 data on a novel dual targeting ADC in prostate cancer. The broader scope of ADC development in prostate cancer is discussed with a focus on cytopenia toxicity and future direcctions.

Episode metadata supplied by the publisher feed · Published Jun 15, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Episode 510: ADCs in Prostate Cancer

0:00 30:23

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Uromigos?

This episode is 30 minutes long.

When was this The Uromigos episode published?

This episode was published on June 15, 2026.

Can I download this The Uromigos episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!